Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F13A1 | P00488 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.31 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | BRAF | P15056 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20499799 | 0.89 | F13A1 (0.39) | F13A1TGM2ALDH1A1TDP1POLB | |
| SCHEMBL20506766 | 0.78 | MEN1 (0.42) | ALDH1A1MAPTL3MBTL1GAATP53 | |
| SCHEMBL17634991 | 0.78 | ALDH1A1 (0.39) | ALDH1A1TDP1MAPTL3MBTL1CYP3A4 | |
| SCHEMBL21707451 | 0.74 | MEN1 (0.37) | ALDH1A1MAPTL3MBTL1GAATP53 | |
| SCHEMBL20506762 | 0.73 | ALDH1A1 (0.33) | ALDH1A1MAPTL3MBTL1GAA | |
| SCHEMBL20527882 | 0.71 | — | — | |
| SCHEMBL19002876 | 0.71 | MAPT (0.42) | ALDH1A1TDP1POLBMAPTL3MBTL1 | |
| SCHEMBL17343555 | 0.71 | MAPT (0.42) | ALDH1A1TDP1MAPTL3MBTL1GAA | |
| SCHEMBL17348254 | 0.71 | CNR2 (0.33) | ALDH1A1POLBMAPTGAACYP3A4 | |
| SCHEMBL21707381 | 0.69 | SMN1; SMN2 (0.37) | ALDH1A1POLBMAPTL3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10316161-B2 | Method of making highly porous polyhexahydrotriazines containing antimicrobial agents | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2019-06-11 | — | — | US | disclosed |
| US-20180265664-A1 | METHOD OF MAKING HIGHLY POROUS POLYHEXAHYDROTRIAZINES CONTAINING ANTIMICROBIAL AGENTS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2018-09-20 | — | — | US | disclosed |
| US-9255104-B2 | Cyclopropyl modulators of P2Y12 receptor | AUSPEX PHARMACEUTICALS, INC. (US) | 2016-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180265664-A1 | METHOD OF MAKING HIGHLY POROUS POLYHEXAHYDROTRIAZINES CONTAINING ANTIMICROBIAL AGENTS | PFAS, PUF60, PARG | F13A1 401/4885TGM2 3850/4885ALDH1A1 2353/4885 |
| US-10316161-B2 | Method of making highly porous polyhexahydrotriazines containing antimicrobial agents | PFAS, PUF60, PARG | F13A1 401/4885TGM2 3850/4885ALDH1A1 2353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.